» Articles » PMID: 27604960

Bacterial Type B RNase P: Functional Characterization of the L5.1-L15.1 Tertiary Contact and Antisense Inhibition

Overview
Journal RNA
Specialty Molecular Biology
Date 2016 Sep 9
PMID 27604960
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Ribonuclease P is the ubiquitous endonuclease that generates the mature 5'-ends of precursor tRNAs. In bacteria, the enzyme is composed of a catalytic RNA (∼400 nucleotides) and a small essential protein subunit (∼13 kDa). Most bacterial RNase P RNAs (P RNAs) belong to the architectural type A; type B RNase P RNA is confined to the low-G+C Gram-positive bacteria. Here we demonstrate that the L5.1-L15.1 intradomain contact in the catalytic domain of the prototypic type B RNase P RNA of Bacillus subtilis is crucial for adopting a compact functional conformation: Disruption of the L5.1-L15.1 contact by antisense oligonucleotides or mutation reduced P RNA-alone and holoenzyme activity by one to two orders of magnitude in vitro, largely retarded gel mobility of the RNA and further affected the structure of regions P7/P8/P10.1, P15 and L15.2, and abolished the ability of B. subtilis P RNA to complement a P RNA-deficient Escherichia coli strain. We also provide mutational evidence that an L9-P1 tertiary contact, as found in some Mycoplasma type B RNAs, is not formed in canonical type B RNAs as represented by B. subtilis P RNA. We finally explored the P5.1 and P15 stem-loop structures as targets for LNA-modified antisense oligonucleotides. Oligonucleotides targeting P15, but not those directed against P5.1, were found to efficiently anneal to P RNA and to inhibit activity (IC of ∼2 nM) when incubated with preassembled B. subtilis RNase P holoenzymes.

Citing Articles

Characterization of RNA-based and protein-only RNases P from bacteria encoding both enzyme types.

Gossringer M, Waber N, Wiegard J, Hartmann R RNA. 2023; 29(3):376-391.

PMID: 36604113 PMC: 9945441. DOI: 10.1261/rna.079459.122.


RNase P Inhibitors Identified as Aggregators.

Schencking I, Schafer E, Scanlan J, Wenzel B, Emmerich R, Steinmetzer T Antimicrob Agents Chemother. 2021; 65(8):e0030021.

PMID: 33972249 PMC: 8284443. DOI: 10.1128/AAC.00300-21.


Critical domain interactions for type A RNase P RNA catalysis with and without the specificity domain.

Mao G, Srivastava A, Wu S, Kosek D, Lindell M, Kirsebom L PLoS One. 2018; 13(3):e0192873.

PMID: 29509761 PMC: 5839562. DOI: 10.1371/journal.pone.0192873.

References
1.
Liu X, Chen Y, Fierke C . A real-time fluorescence polarization activity assay to screen for inhibitors of bacterial ribonuclease P. Nucleic Acids Res. 2014; 42(20):e159. PMC: 4227764. DOI: 10.1093/nar/gku850. View

2.
Kazantsev A, Rambo R, Karimpour S, SantaLucia Jr J, Tainer J, Pace N . Solution structure of RNase P RNA. RNA. 2011; 17(6):1159-71. PMC: 3096047. DOI: 10.1261/rna.2563511. View

3.
Svard S, Mattsson J, Johansson K, Kirsebom L . Cloning and characterization of the RNase P RNA genes from two porcine mycoplasmas. Mol Microbiol. 1994; 11(5):849-59. DOI: 10.1111/j.1365-2958.1994.tb00363.x. View

4.
Gruegelsiepe H, Brandt O, Hartmann R . Antisense inhibition of RNase P: mechanistic aspects and application to live bacteria. J Biol Chem. 2006; 281(41):30613-20. DOI: 10.1074/jbc.M603346200. View

5.
Haas E, Banta A, Harris J, Pace N, Brown J . Structure and evolution of ribonuclease P RNA in Gram-positive bacteria. Nucleic Acids Res. 1996; 24(23):4775-82. PMC: 146312. DOI: 10.1093/nar/24.23.4775. View